NDC 0069-1029-01 - XELJANZ
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-1029
- Requested NDC
- 0069-1029-01
- Package NDCs from labels
- 0069-1029-01, 0069-1029-02
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc | Viatris Pharmaceuticals LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH | Pharmacia & Upjohn Company LLC | Pfizer Asia Manufacturing Pte Ltd
- Effective date
- 2026-09-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| XELJANZ | Pfizer Laboratories Div Pfizer Inc | Viatris Pharmaceuticals LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH | Pharmacia & Upjohn Company LLC | Pfizer Asia Manufacturing Pte Ltd | 2026-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-1029-01 | XELJANZ | 240 mL in 1 BOTTLE | SOLUTION | 240 | 53 | |
| 0069-1029-02 | XELJANZ | 1 in 1 CARTON | SOLUTION | 1 | 53 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0069-1029 | XELJANZ (TOFACITINIB) TABLET, FILM COATED XELJANZ XR (TOFACITINIB) TABLET, FILM COATED, EXTENDED RELEASE XELJANZ (TOFACITINIB) SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 49 | Current NDC, Legacy NDC, 2 package rows | 20241222_cf74ba2f-afc5-4baa-8594-979c889a5831.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-1029-01 | ML - Milliliter | 0069-1029 | e8f5459b-9e04-49e2-9207-b8563b645f0a | 1 | 2021-03-02 |
| 0069-1029-02 | ML - Milliliter | 0069-1029 | ab3afb2e-c7a8-4c8c-b7d7-2c29d2947f52 | 1 | 2021-03-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| TOFACITINIB | TOFACITINIB | Sun Pharmaceutical Industries, Inc. | a764a133-b870-4514-bbee-24d43f8cb7fd | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 2478433 O1FF4DIV0D |
| Polyethylene Glycol 3350 | INSTALAX POLYETHYLENE GLYCOL 3350 | Sun Pharmaceutical Industries, Inc. | 40bd1be7-de67-8dff-e063-6294a90aca95 | 2026-07-24 | Warnings | G2M7P15E5P |
| ESIKA COLORFIX POLVOS 32H POLVO COMPACTO FACIAL DE ALTA COBERTURA FPS 15 110-C | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | BEL STAR S.A. | 575fb2c3-e332-8a3b-e063-6394a90a9fd9 | 2026-07-24 | Warnings | 15FIX9V2JP |
| Neutraflush | EYEWASH STATION ADDITIVE CONCENTRATE | Aero Healthcare | 1d9ff2ef-9c9b-f367-e063-6294a90afa0e | 2026-07-24 | Warnings | 6DC9Q167V3 |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | G2M7P15E5P |
| PRENATE Restore | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN, CALCIUM CARBONATE, FERROUS FUMARATE, MAGNESIUM OXIDE, LACTIC ACID AND DOCONEXENT | Avion Pharmaceuticals, LLC | 1076ba9a-0168-492f-ba9b-99fa02186092 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 33X04XA5AT |
| Tofacitinib | TOFACITINIB | AvKARE | 5751321a-c904-44ae-e063-6394a90a2654 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 2048566 1357541 O1FF4DIV0D |
| True Coast SPF 50 Mineral Sunscreen | ZINC OXIDE 18%, TITANIUM DIOXIDE 6% | Foshan Sugar Max Cosmetics CO.,Ltd | 5379466d-8d14-5fc2-e063-6394a90abd7e | 2026-07-22 | Warnings | 15FIX9V2JP |
| Calamine | CALAMINE AND ZINC OXIDE | Marie's Original Formulas LLC | 57110309-9a3d-025f-e063-6394a90a015a | 2026-07-22 | Warnings | 1K09F3G675 |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Radha Pharmaceuticals, Inc. | 141ab3eb-982b-4242-89db-6ddce5be0c40 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | ScieGen Pharmaceuticals, INC. | 11d08738-efa3-4474-8eda-812bc04adfbb | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| Yves Saint Laurent All Hours Foundation Sunscreen Broad Spectrum SPF 30 Luminous Matte Foundation | OCTINOXATE AND TITANIUM DIOXIDE | SICOS ET CIE | 571f23e9-1126-e32d-e063-6294a90a9951 | 2026-07-21 | Warnings | 15FIX9V2JP |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| MENS SPF50 ALL IN ONE SUNSCREEN | MENS SPF50 ALL IN ONE SUNSCREEN | Lance (Guangzhou) Biological Technology Co., Ltd. | 57074480-77fd-cc06-e063-6294a90a28d4 | 2026-07-20 | Warnings | 15FIX9V2JP |
| Calamine | CALAMINE AND ZINC OXIDE | Marie's Original Formulas LLC | 571083ce-cd35-a638-e063-6394a90ae4c7 | 2026-07-20 | Warnings | 1K09F3G675 |
| Yves Saint Laurent All Hours Foundation Sunscreen Broad Spectrum SPF 30 Luminous Matte Foundation | OCTINOXATE AND TITANIUM DIOXIDE | L'Oreal USA Products Inc | 5711364c-f9b4-bfa6-e063-6294a90ace4a | 2026-07-20 | Warnings | 15FIX9V2JP |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | e54b186f-e42a-4477-939c-8dd331045fbe | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 1741046 O1FF4DIV0D |
| FUNGAL NAIL TREATMENT kit .cream. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 | 2026-07-17 | Warnings | 6DC9Q167V3 |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | 50962b08-99dd-ae73-e063-6394a90ad1eb | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | 2048566 1357541 O1FF4DIV0D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.